Biotech Values

[DewDiligence]

I’m taking down the Genentech survey (#msg-36329285) because today’s disclosures in #msg-37028924 provide the answers about Roche’s ability to retain Genentech’s top technical people.

 
                    Old DNA         New Roche 
                    Position        Position  
 Art Levinson       CEO             Non-employee director 
 Sue Hellmann       President       Non-employee advisor 
 Richard Scheller   EVP Research    Head of embedded R&D group 
 M. Tessier-Lavigne EVP Drug Disvry CSO 
 Hal Barron         CMO             Head of oncology development 
 Andre Chan         SVP, Research   Unknown 
 Napoleone Ferrara  Fellow          Unknown

All told, 3-4 of the 6 executives in the first question of the survey will be staying on as employees, which is pretty impressive from Roche’s standpoint, IMO.

The most significant career step-up for any of Genentech’s high-ranking executives would appear to be Ian Clark (who was not part of the survey); Clark will become the head of worldwide marketing for Roche’s pharma business.